11 news items
Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06)
MBRX
15 May 24
Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Although Moleculin believes
Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update
MBRX
13 May 24
Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press
Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin
MBRX
9 May 24
27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which
Moleculin Reports Higher AML Complete Remission (CR) Rates and Significant Durability with Additional Interim Subject Data
MBRX
7 May 24
, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties
Moleculin Announces Formation of Scientific Advisory Board to Support Development of Annamycin
MBRX
1 May 24
the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform
n1tgs3yuce5r7v96umsqq6q3hxyn5kqjwupz ec
MBRX
18 Apr 24
of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking
sgjik7f2f5kwxirt3uridg8r 1zxi018yo9bu4ebnope2o98qz1m7p0hpw
MBRX
10 Apr 24
, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties
ri577mo68a76gnnw dpvjgs5p
MBRX
27 Mar 24
Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation
6erkrgahyph7spyt626p0uzr568o7wyceetzuzl flba6xqnhw2fd9c
MBRX
25 Mar 24
Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation
8cp5jwfmcakh5u1xgyrrwmqov49djdy41lrrki9qtbtdysx2
MBRX
22 Mar 24
of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995
wcpks9sb3ewybgx9pvsqukjrtwzzk8sw i72nxvf
MBRX
19 Mar 24
, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward
- Prev
- 1
- Next